Overview / Abstract: |
STATEMENT OF NEED Many tumors, such as prostate, breast, lung, and multiple myeloma, affect bone health. Once cancer spreads to the skeletal system, the risk for pain, fractures, hypercalcemia, and nerve compression increases considerably. Several studies have shown that the use of antiresorptive agents such as bisphosphonates and monoclonal antibodies can reduce the morbidity of skeletal complications in patients with cancer and significantly improve quality of life. Combined with preventive measures to reduce bone thinning, early clinical trial results have shown that bone targeting agents can prolong survival in patients with cancer and bone involvement. However, delayed treatment is associated with high morbidity and mortality; therefore, bone health complications in patients with cancer must be promptly recognized and managed. TARGET AUDIENCE Oncology nurses, nurse practitioners, clinical nurse specialists, and other health care professionals involved in the treatment of patients with cancer. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: 1. Describe patient- and cancer therapy-related risk factors for bone complications |
Expiration |
Feb 14, 2020 |
Discipline(s) |
Nurse Practitioner , Nursing CNE |
Format |
Monograph, Online |
Credits / Hours |
1.0 |
Accreditation |
ANCC |
Keywords / Search Terms |
i3 Health i3 Health, oncology, cancer, bone health, supportive care, CE, free CE, online CE Free CE CME |